UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Angiotensin II receptor antagonists

The Lancet (British edition), 2000-02, Vol.355 (9204), p.637-645

2000

Volltextzugriff (PDF)

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

Clinical pharmacology and therapeutics, 1999-07, Vol.66 (1), p.76-84

1999

Volltextzugriff (PDF)

The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview

Journal of human hypertension, 2002-05, Vol.16 (S2), p.S13-S16

BRUNNER, H. R

2002

Volltextzugriff (PDF)

Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells

Arteriosclerosis, thrombosis, and vascular biology, 1998-05, Vol.18 (5), p.686-692

1998

Volltextzugriff (PDF)

Blood Pressure-Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System

Hypertension (Dallas, Tex. 1979), 1998-06, Vol.31 (6), p.1324-1330

1998

Volltextzugriff (PDF)

Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice

Hypertension (Dallas, Tex. 1979), 2000-04, Vol.35 (4), p.985-991

2000

Volltextzugriff (PDF)

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout

Journal of hypertension, 2001-10, Vol.19 (10), p.1855-1860

2001

Volltextzugriff (PDF)

Endothelial function in chronic congestive heart failure

The American journal of cardiology, 1992-06, Vol.69 (19), p.1596-1601

1992

Volltextzugriff (PDF)

Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular Hypertension

The Journal of biological chemistry, 2000-12, Vol.275 (52), p.40867-40873

2000

Volltextzugriff (PDF)

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers : inhibition of pressor response to exogenous angiotensin I and II

Circulation (New York, N.Y.), 1991-04, Vol.83 (4), p.1333-1342

1991

Volltextzugriff (PDF)

Renal effects of angiotensin II receptor blockade in normotensive subjects

Kidney international, 1996-06, Vol.49 (6), p.1787-1790

1996

Volltextzugriff (PDF)

Isolated office hypertension: a prehypertensive state?

Journal of hypertension, 1996-03, Vol.14 (3), p.327-332

1996

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects

European journal of clinical pharmacology, 1999-11, Vol.55 (9), p.633-637

1999

Volltextzugriff (PDF)

Endogenous Angiotensin II Induces Atherosclerotic Plaque Vulnerability and Elicits a Th1 Response in ApoE−/− Mice

Hypertension (Dallas, Tex. 1979), 2004-09, Vol.44 (3), p.277-282

2004

Volltextzugriff (PDF)

Determinants of Angiotensin II Generation During Converting Enzyme Inhibition

Hypertension (Dallas, Tex. 1979), 1990-11, Vol.16 (5), p.564-572

1990

Volltextzugriff (PDF)

Synergistic effects of fluid shear stress and cyclic circumferential stretch on vascular endothelial cell morphology and cytoskeleton

Arteriosclerosis, thrombosis, and vascular biology, 1995-10, Vol.15 (10), p.1781-1786

1995

Volltextzugriff (PDF)

Salt-Dependent Renal Effects of an Angiotensin II Antagonist in Healthy Subjects

Hypertension (Dallas, Tex. 1979), 1993-09, Vol.22 (3), p.339-337

1993

Volltextzugriff (PDF)

The multifactorial nature of hypertension: the greatest challenge for its treatment?

Journal of hypertension. Supplement, 2001-09, Vol.19 (3), p.S9-16

2001

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists

Clinical pharmacokinetics, 1997, Vol.32 (1), p.1-29

1997

Volltextzugriff (PDF)

Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system

American journal of physiology. Heart and circulatory physiology, 1995-06, Vol.268 (6), p.H2267-H2273

1995

Volltextzugriff (PDF)

Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells

American Journal of Physiology: Cell Physiology, 1994-04, Vol.266 (4), p.C1118-C1127

1994

Volltextzugriff (PDF)

Angiotensin II receptor antagonists in hypertension

Kidney international, 1998-12, Vol.54 (S68), p.S107-S111

1998

Volltextzugriff (PDF)

Shorter PFA-100-closure times in laparoscopic versus conventional hysterectomy are not caused by increased vasopressin levels

Thrombosis research, 2006, Vol.118 (2), p.229-234

2006

Volltextzugriff (PDF)

Compliance with Antihypertensive Therapy

Clinical and experimental hypertension (1993), 1999, Vol.21 (5-6), p.973-985

1999

Volltextzugriff (PDF)

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions

Journal of hypertension, 2001-02, Vol.19 (2), p.335-341

2001

Volltextzugriff (PDF)

1 – 25 von 3.338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.843)
Mit Volltextzugriff
(2.517)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.930)
Life Sciences & Biomedicine
(1.413)
Humans
(1.385)
Male
(881)
Female
(746)
Biological And Medical Sciences
(674)
Medical Sciences
(563)
Adult
(554)
Middle Aged
(479)
Physical Sciences
(458)
Animals
(393)
Cardiovascular System & Cardiology
(340)
Aged
(319)
Physics
(304)
Blood Pressure - Drug Effects
(262)
Cardiac & Cardiovascular Systems
(209)
Pharmacology. Drug Treatments
(196)
Adolescent
(195)
Pharmacology & Pharmacy
(180)
Hypertension - Drug Therapy
(173)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Angiotensin II receptor antagonists

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview

Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells

Blood Pressure-Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System

Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout

Endothelial function in chronic congestive heart failure

Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular Hypertension

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers : inhibition of pressor response to exogenous angiotensin I and II

Renal effects of angiotensin II receptor blockade in normotensive subjects

Isolated office hypertension: a prehypertensive state?

Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects

Endogenous Angiotensin II Induces Atherosclerotic Plaque Vulnerability and Elicits a Th1 Response in ApoE−/− Mice

Determinants of Angiotensin II Generation During Converting Enzyme Inhibition

Synergistic effects of fluid shear stress and cyclic circumferential stretch on vascular endothelial cell morphology and cytoskeleton

Salt-Dependent Renal Effects of an Angiotensin II Antagonist in Healthy Subjects

The multifactorial nature of hypertension: the greatest challenge for its treatment?

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists

Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system

Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells

Angiotensin II receptor antagonists in hypertension

Shorter PFA-100-closure times in laparoscopic versus conventional hysterectomy are not caused by increased vasopressin levels

Compliance with Antihypertensive Therapy

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions

Suchergebnisse filtern